论文部分内容阅读
目的探讨射频消融术治疗原发性肝癌的临床疗效。方法 84例肝癌患者共95个肝脏恶性肿瘤行CT引导下射频消融术治疗,术后患者均行定期随访、复查。结果 95例癌灶射频消融治疗均获得成功。术后3个月CT或MRI复查,缓解率为91.67%,完全缓解率为65.48%。各组之间的完全缓解率及缓解率的差异均有统计学意义(P<0.05)。AFP从(646±757)IU/L降至(250±267)IU/L(P<0.05)。6、12、20个月生存率分别是100.00%、95.23%、92.86%。结论射频消融术做为一种微创治疗方法 ,操作简单创伤小,术后并发症少、恢复快,对肝癌的治疗有很好的临床效果。
Objective To investigate the clinical efficacy of radiofrequency ablation in the treatment of primary liver cancer. Methods A total of 95 liver malignancies in 84 patients with hepatocellular carcinoma underwent CT-guided radiofrequency catheter ablation. Postoperative patients underwent regular follow-up and review. Results All the 95 cases of tumor radiofrequency ablation were successful. 3 months after CT or MRI review, the response rate was 91.67%, the complete response rate was 65.48%. The complete remission rate and remission rate between the two groups were statistically significant (P <0.05). AFP decreased from (646 ± 757) IU / L to (250 ± 267) IU / L (P <0.05). The survival rates at 6, 12 and 20 months were 100.00%, 95.23% and 92.86% respectively. Conclusion Radiofrequency catheter ablation is a minimally invasive treatment, which has the advantages of simple operation, less trauma, less postoperative complications, rapid recovery and good clinical effect on the treatment of liver cancer.